| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From The Wien Center for Alzheimer’s Disease and Memory Disorders (D.G. Harwood and W.W. Barker, and Drs. Loewenstein, Ownby, and Duara), Mount Sinai Medical Center and University of Miami School of Medicine; the Department of Psychiatry and Behavioral Sciences (Drs. Loewenstein, Ownby, and Duara), University of Miami School of Medicine; the Division of Neurology, Departments of Medicine and Physiology (Dr. George-Hyslop), the Center for Research in Neurodegenerative Diseases, University of Toronto; Roskamp Laboratories, Department of Psychiatry (Dr. Mullan), University of South Florida; and the Departments of Medicine and Neurology (Dr. Duara), University of Miami School of Medicine, Miami, FL.
Address correspondence and reprint requests to Dr. Ranjan Duara, Wien Center, Mount Sinai Medical Center, 4300 Alton Road, Miami Beach, FL 33140.
BACKGROUND: The prevalence of AD appears to vary widely in different ethnic groups. Certain risk factors for AD are well established for the general population, but there is little information regarding the relevance of these risk factors in specific ethnic groups.
OBJECTIVE: The authors examined the risk of AD associated with the APOE-
4 allele, the APOE-2 allele, smoking, alcohol consumption, history of hypertension, low educational level, estrogen replacement therapy, and history of head trauma with loss of consciousness among samples of white non-Hispanics (WNH) (392 AD patients, 202 normal subjects) and white Hispanics (WHIS) (188 AD patients, 84 normal controls).Design:— This was a case-control study of patients evaluated at an outpatient memory disorders clinic and control subjects recruited from a free memory screening offered to the community.
RESULTS: Increased risk for AD was associated with the APOE-4 allele after controlling for age, education, and gender among WNH (OR = 3.5; 95% CI = 2.3 to 5.5) and WHIS (OR = 3.1; 95% CI = 1.7 to 5.8). No protective effect was conferred by the APOE-2 allele, although this relationship approached significance among WNH (p = 0.02). Low levels of education increased the risk for AD among WNH (OR = 3.1; 95% CI = 1.8 to 5.9) but not WHIS. Alcohol use and hypertension approached significance as risk factors in WNH (p < 0.05) but not WHIS. Estrogen replacement treatment approached significance as a protective factor in both ethnic groups (p < 0.05).
CONCLUSIONS: Although the APOE-4 allele is a risk factor for AD among WHIS and WNH, other risk factors such as low education and hypertension appear to be important only for WNH. Risk factors for AD reported or suggested previously that were not confirmed by this study include smoking and head trauma with loss of consciousness.
This article has been cited by other articles:
|
|
 |
|
  M. Sano, D. Jacobs, H. Andrews, K. Bell, N. Graff-Radford, J. Lucas, P. Rabins, K. Bolla, W.-Y. Tsai, P. Cross, et al. A multi-center, randomized, double blind placebo-controlled trial of estrogens to prevent Alzheimer's disease and loss of memory in women: design and baseline characteristics Clinical Trials, October 1, 2008; 5(5): 523 - 533. [Abstract] [PDF]
|
|
|
|
 |
|
 C. M. Clark, C. DeCarli, D. Mungas, H. I. Chui, R. Higdon, J. Nunez, H. Fernandez, M. Negron, J. Manly, S. Ferris, et al. Earlier Onset of Alzheimer Disease Symptoms in Latino Individuals Compared With Anglo Individuals Arch Neurol, May 1, 2005; 62(5): 774 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J-C Lambert, N Coyle, and C Lendon The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer's disease J. Med. Genet., February 1, 2004; 41(2): 104 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Fleminger, D L Oliver, S Lovestone, S Rabe-Hesketh, and A Giora Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication J. Neurol. Neurosurg. Psychiatry, July 1, 2003; 74(7): 857 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. D. Nelson, L. L. Humphrey, P. Nygren, S. M. Teutsch, and J. D. Allan Postmenopausal Hormone Replacement Therapy: Scientific Review JAMA, August 21, 2002; 288(7): 872 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. N. Romas, V. Santana, J. Williamson, A. Ciappa, J. H. Lee, H. Z. Rondon, P. Estevez, R. Lantigua, M. Medrano, M. Torres, et al. Familial Alzheimer Disease Among Caribbean Hispanics: A Reexamination of Its Association With APOE Arch Neurol, January 1, 2002; 59(1): 87 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gatz, P. Svedberg, N. L. Pedersen, J. A. Mortimer, S. Berg, and B. Johansson Education and the Risk of Alzheimer's Disease: Findings From the Study of Dementia in Swedish Twins J. Gerontol. B. Psychol. Sci. Soc. Sci., September 1, 2001; 56(5): P292 - 300. [Abstract] [Full Text]
|
|
|
|
|
|
E. S. LeBlanc, J. Janowsky, B. K. S. Chan, and H. D. Nelson Hormone Replacement Therapy and Cognition: Systematic Review and Meta-analysis JAMA, March 21, 2001; 285(11): 1489 - 1499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Harwood, W. W. Barker, R. L. Ownby, M. J. Mullan, and R. Duara Family History of Dementia and Current Depression in Nondemented Community-Dwelling Older Adults J Geriatr Psychiatry Neurol, July 1, 2000; 13(2): 65 - 71. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
